In this study, we examined for the first time the level of genomic 5-hmc and its link with TET2 mutation or expression in a cohort of ATLL patients suffering from either chronic or aggressive ATLL. This evidence concerns the gene TET2 and adult T-cell leukemia/lymphoma.